<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002138'>Subarachnoid haemorrhage</z:hpo> (SAH) caused by a ruptured <z:hpo ids='HP_0002617'>aneurysm</z:hpo> accounts for only 5% of <z:hpo ids='HP_0001297'>strokes</z:hpo>, but occurs at a fairly young age and carries a worse prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Delayed <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> (DCI) is an important cause of <z:hpo ids='HP_0011420'>death</z:hpo> and dependence after aneurysmal <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The current mainstay of preventing DCI is nimodipine and maintenance of normovolemia, but even with this strategy DCI occurs in a considerable proportion of patients </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="131" ids="25107">Magnesium</z:chebi> is an inexpensive, easily available neuroprotective agent and has been shown to reduce <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after experimental SAH </plain></SENT>
<SENT sid="4" pm="."><plain>In a subgroup analysis in the Cochrane review of <z:hpo ids='HP_0000001'>all</z:hpo> randomized clinical trials of calcium <z:chebi fb="68" ids="48706">antagonists</z:chebi> in SAH, <z:chebi fb="131" ids="25107">magnesium</z:chebi> reduced the occurrence of DCI and that of poor outcome </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="131" ids="25107">Magnesium</z:chebi> is a promising agent to prevent the occurrence of secondary <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and to improve outcome in patients with SAH </plain></SENT>
<SENT sid="6" pm="."><plain>Currently two large phase Il trials are being conducted that will hopefully provide definite evidence whether <z:chebi fb="131" ids="25107">magnesium</z:chebi> treatment is beneficial in SAH patients </plain></SENT>
</text></document>